ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,475.09
      0.27%
      US Tech 100
      19,276.80
      0.00%
      Dow Jones
      39,169.52
      0.13%
      Brent Oil
      86.515
      -0.02%
      Bitcoin
      62,505.56
      -0.55%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Olema Pharmaceuticals Inc (OLMA)

      7. Olema Pharmaceuticals Inc (OLMA) News

      OLMA

      Olema Pharmaceuticals (OLMA)

      Olema Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:OLMA
      DateTimeSourceHeadlineSymbolCompany
      11/03/20239:39PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OLMAOlema Pharmaceuticals Inc
      11/03/20239:39PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OLMAOlema Pharmaceuticals Inc
      11/03/20239:39PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OLMAOlema Pharmaceuticals Inc
      11/03/20234:53PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:OLMAOlema Pharmaceuticals Inc
      11/02/20238:50PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OLMAOlema Pharmaceuticals Inc
      11/02/20234:46PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:OLMAOlema Pharmaceuticals Inc
      11/02/20234:32PMGlobeNewswire Inc.Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:OLMAOlema Pharmaceuticals Inc
      11/02/20234:21PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:OLMAOlema Pharmaceuticals Inc
      11/01/20234:49PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:OLMAOlema Pharmaceuticals Inc
      11/01/20234:49PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:OLMAOlema Pharmaceuticals Inc
      11/01/20234:27PMGlobeNewswire Inc.Olema Oncology to Participate in Upcoming Investor Conferences in NovemberNASDAQ:OLMAOlema Pharmaceuticals Inc
      10/31/202310:38AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:OLMAOlema Pharmaceuticals Inc
      10/23/20237:45AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OLMAOlema Pharmaceuticals Inc
      10/22/20232:55AMGlobeNewswire Inc.Olema Oncology Announces Positive Phase 2 Monotherapy Clinical Study Results for PalazestrantNASDAQ:OLMAOlema Pharmaceuticals Inc
      10/18/20234:46PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:OLMAOlema Pharmaceuticals Inc
      10/17/20237:33AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OLMAOlema Pharmaceuticals Inc
      10/17/20237:01AMGlobeNewswire Inc.Olema Oncology Appoints Oncology Biotech Executive Scott Garland to Board of DirectorsNASDAQ:OLMAOlema Pharmaceuticals Inc
      10/16/20237:02AMGlobeNewswire Inc.Olema Oncology Announces Phase 2 Monotherapy Clinical Results to be Presented at the 2023 ESMO CongressNASDAQ:OLMAOlema Pharmaceuticals Inc
      10/12/20237:01AMGlobeNewswire Inc.Olema Oncology KAT6 Inhibitor Compounds Demonstrate Potent Anti-Tumor ActivityNASDAQ:OLMAOlema Pharmaceuticals Inc
      10/10/20237:17AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OLMAOlema Pharmaceuticals Inc
      10/10/20237:00AMGlobeNewswire Inc.Olema Oncology Announces Expansion of Collaboration Agreement with NovartisNASDAQ:OLMAOlema Pharmaceuticals Inc
      10/03/20235:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OLMAOlema Pharmaceuticals Inc
      10/03/20234:30PMGlobeNewswire Inc.Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:OLMAOlema Pharmaceuticals Inc
      09/29/202311:05AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:OLMAOlema Pharmaceuticals Inc
      09/21/20235:12PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:OLMAOlema Pharmaceuticals Inc
      09/21/20235:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OLMAOlema Pharmaceuticals Inc
      09/20/20237:29AMGlobeNewswire Inc.Olema Oncology Announces New Preclinical KAT6 Inhibitor Data to be Presented at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer TherapeuticsNASDAQ:OLMAOlema Pharmaceuticals Inc
      09/19/20235:07PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:OLMAOlema Pharmaceuticals Inc
      09/14/20234:14PMEdgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:OLMAOlema Pharmaceuticals Inc
      09/13/20235:22PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:OLMAOlema Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:OLMA

      Your Recent History

      TG
      FLPE
      Flexshares Listed Privat...
      Delayed Upgrade Clock